Controversies on Special Products for Managing Cow’s Milk Protein Allergy in Infants: Safety and Suitability

The aim of the symposium was to share learnings from the recently established European Academy of Allergy and Clinical Immunology (EAACI) Task Force on special products for cow’s milk protein allergy (CMPA), with the intention of providing an overview on controversies regarding extensively hydrolysed formulas (eHFs), their utility, and the validity of the definition ‘special products ...

This article's user rating is

Want to find out more?

OR LOGIN IF YOU ARE ALREADY REGISTERED